SwitchGear Genomics Active Motif Acquires SwitchGear Genomics NEW YORK (GenomeWeb News) – Active Motif announced Thursday that it has acquired privately held genomics tools maker SwitchGear Genomics for an undisclosed price. SwitchGear, New England Biolabs Collaborate on New Dual Reporter Assay System NEW YORK (GenomeWeb News) – SwitchGear Genomics today said it has partnered with New England Biolabs to develop a new dual reporter assay system. Cosmo Bio Distributing SwitchGear System in Japan Cosmo Bio will distribute the LightSwitch Luciferase Assay System with marketing and technical support from SwitchGear. BioCat to Distribute SwitchGear System in Europe BioCat will distribute the firm's LightSwitch Luciferase Assay System in select European countries. SwitchGear Providing Roche's FuGene HD Reagent Under the distribution agreement, SwitchGear will offer the reagent as a standalone product as well as part of its own LightSwitch Transfection Optimization kit. Aug 9, 2010 Sigma-Aldrich, SwitchGear Co-developing miRNA Target Validation System Nov 18, 2009 Promega, SwitchGear Collaborate on DNA-Protein Interactions Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.